By
Olumide AdesinaEuropean Stocks hovered at 8-month highs, on optimism around signs of
a breakthrough of Pfizer’s COVID-19 vaccine. Although concerns on the
negative disruption caused by the COVID-19 pandemic weighed heavily on
global investors.
- On a W/W performance review, the Spanish Stock index, IBEX, up 13.13%.
- French Stock in CAC 40 up 12.59% outmatched its American rivals Dow Jones 30 up 6.11% and S&P 500 up by 5.38%
What this means: European equity markets are
consolidating following yesterday´s impressive rally. The US
presidential election and the COVID-19 pandemic were the two major
topics that kept investors on the edge during the past few weeks. Now,
they can finally breathe a sigh of relief.
European stocks are all fired up on the bias that investors cheer the
possibility of a peaceful global trade regime under U.S.
President-elect, Joe Biden. However, surging COVID-19 cases have
threatened a fragile economic recovery at home.
What they are saying
Stephen Innes, Chief Global Market Strategist at
Axi, in an explanatory note to Nairametrics, provided key insights on
macros boosting European Stocks rally.
“US and European equities soared overnight amid a most frothy
global risk rally, but gold was down nearly 5% on the back of far better
than expected results by the vaccine candidate developed by Pfizer and
BioNTech.
“Those results showed a more than 90% effectiveness rate among 94
subjects infected with COVID-19 and who had at least one symptom.
“Pfizer indicated it remains on target to seek sale permission
from regulators by the end of this month. Depending on how long
regulators take to review it, the distribution could then start within
months.”
Bottom Line
There is a lot for Stock traders to take in right now, not to mention
that the blue party’s electoral victory at the U.S presidential
election has ushered in a perceived transformation in geopolitical risk,
as investors debate how the world might be a more peaceful place during
the next four years.
No comments :
Post a Comment